Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report By Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, And Others), Service Type (Target Identification And Validation, Lead Screening And Characterization And Cell Based Assays), Cancer Type (Lung, Breast, Colorectal, Melanoma, Prostate, Head And Neck, Ovarian And Pancreatic) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11211227
August 2019
Report Formats:

As per this study the Global Cancer Immunotherapy Drug Discovery outsourcing Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of XX.X%.
 
Cancer immunotherapy drug discovery outsourcing defined as outsourcing of research activities which helps in optimizing funds and time involved in the process of drug discovery. These is done for various cancer type such as lung, breast, colorectal, melanoma, prostate, head and neck, ovarian and pancreatic cancer.
 
Market Dynamics
 
The rising prevalence of cancer disease along with the growing awareness among consumers for the treatment of cancer across the globe is driving the market growth. Also, the increasing expenditure on R&D in the healthcare industry and favorable government campaigns for cancer treatment are again fuelling market growth. Additionally, advanced technologies for more refined, accurate, and less time-consuming drug discovery is further boosting the market growth. On the other hand, excessive cost and time associated with initial drug discovery may hamper market growth. Whereas, ongoing technological advancements in biotechnology and genomics are expected to create potential opportunity during the forecast timeframe.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cancer immunotherapy drug discovery outsourcing.
 
Market Segmentation
 
The broad cancer immunotherapy drug discovery outsourcing market has been sub-grouped into drug type, service type, and cancer type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Drug Type

  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies And Cancer Vaccines
  • Others
 
By Service Type
  • Target Identification And Validation
  • Lead Screening And Characterization
  • Cell Based Assays
 
By Cancer Type
  • Lung
  • Breast
  • Colorectal
  • Melanoma
  • Prostate
  • Head And Neck
  • Ovarian
  • Pancreatic
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cancer immunotherapy drug discovery outsourcing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Cancer Immunotherapy Drug Discovery Outsourcing Market By Revenue (USD MN)
 
Europe Cancer Immunotherapy Drug Discovery Outsourcing Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cancer immunotherapy drug discovery outsourcing market includes Aquila BioMedical, BPS Bioscience, Inc., Celentyx Ltd., Covance, Inc., Crown Bioscience, Inc., DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences Co., Ltd., Horizon Discovery Group PLC, ImmunXperts SA, Molecular Imaging, Inc., Personalis, Inc., Promega Corporation and STC Biologics. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Cancer Immunotherapy Drug Discovery Outsourcing
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE
  • Market In Monoclonal Antibodies
  • Market In Immunomodulators
  • Market In Oncolytic Viral Therapies and Cancer Vaccines
  • Market In Others
 
5. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE
  • Market In Target Identification and Validation
  • Market In Lead Screening and Characterization
  • Market In Cell Based Assays
 
6. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE
  • Market In Lung
  • Market In Breast
  • Market In Colorectal
  • Market In Melanoma
  • Market In Prostate
  • Market In Head and Neck
  • Market In Ovarian
  • Market In Pancreatic
 
7. CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
8. COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
9. COMPANY PROFILES OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Aquila BioMedical
  • BPS Bioscience, Inc.
  • Celentyx Ltd.
  • Covance, Inc.
  • Crown Bioscience, Inc.
  • DiscoverX Corporation
  • Explicyte
  • Genscript Biotech Corporation
  • HD Biosciences Co., Ltd.
  • Horizon Discovery Group PLC
  • ImmunXperts SA
  • Molecular Imaging, Inc.
  • Personalis, Inc.
  • Promega Corporation
  • STC Biologics
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Cancer Immunotherapy Drug Discovery Outsourcing
Table 2.  Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Drug Type
Table 3.  Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Service Type
Table 4.  Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Cancer Type
Table 5.  Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Geography
Table 6.  North America Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 7.  Europe Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 8.  Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 9.  Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 10. Middle East And Africa Cancer Immunotherapy Drug Discovery Outsourcing Market 
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Cancer Immunotherapy Drug Discovery Outsourcing Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Cancer Immunotherapy Drug Discovery Outsourcing
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Drug Type
Fig. 8.     Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Service Type
Fig. 9.     Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Cancer Type
Fig. 10.   Global Cancer Immunotherapy Drug Discovery Outsourcing Market By Geography
Fig. 11.   North America Cancer Immunotherapy Drug Discovery Outsourcing Market
Fig. 12.   Europe Cancer Immunotherapy Drug Discovery Outsourcing Market
Fig. 13.   Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market
Fig. 14.   Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market
Fig. 15.   Middle East And Africa Cancer Immunotherapy Drug Discovery Outsourcing Market
Fig. 16.   Market Share Of Cancer Immunotherapy Drug Discovery Outsourcing Companies
Fig. 17.   Recent Developments In Cancer Immunotherapy Drug Discovery Outsourcing Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials